Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis
View through CrossRef
Natalizumab is indicated as monotherapy for the treatment of relapsing-remitting multiple sclerosis; it prevents outbreaks and delays the progression of physical disability. Here, we report the case of a 30-year-old patient with multiple sclerosis receiving natalizumab as monotherapy who subsequently developed self-limited cytomegalovirus disease. Cytomegalovirus infection has been reported during treatment with natalizumab, and in this study, we use new techniques to analyze the possible association of cytomegalovirus infection with natalizumab.
Title: Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis
Description:
Natalizumab is indicated as monotherapy for the treatment of relapsing-remitting multiple sclerosis; it prevents outbreaks and delays the progression of physical disability.
Here, we report the case of a 30-year-old patient with multiple sclerosis receiving natalizumab as monotherapy who subsequently developed self-limited cytomegalovirus disease.
Cytomegalovirus infection has been reported during treatment with natalizumab, and in this study, we use new techniques to analyze the possible association of cytomegalovirus infection with natalizumab.
Related Results
Treatment with natalizumab and ocrelizumab in multiple sclerosis
Treatment with natalizumab and ocrelizumab in multiple sclerosis
In this thesis, our research regarding personalized treatment with natalizumab and ocrelizumab in multiple sclerosis (MS) by extending treatment intervals and the road towards impl...
Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
Background: There is a lack of knowledge about the evolution of cerebrospinal fluid (CSF) markers in multiple sclerosis (MS) patients undergoing natalizumab treatment. Aim: We aime...
Extended interval dosing of natalizumab: a two-center, 7-year experience
Extended interval dosing of natalizumab: a two-center, 7-year experience
Background: The enthusiasm for natalizumab, a highly efficacious agent in the treatment of multiple sclerosis (MS), has been tempered by the risks of progressive multifocal leukoen...
CYTOMEGALOVIRUS INFECTION IN PREGNANT WOMEN WITH HIV INFECTION
CYTOMEGALOVIRUS INFECTION IN PREGNANT WOMEN WITH HIV INFECTION
Purpose: еstablishment of the frequency of infection and clinical forms of cytomegalovirus infection in pregnant women with HIV infection. Materials and methods. A retrospective an...
THUR 171 Natalizumab effectiveness and safety in top uk patients
THUR 171 Natalizumab effectiveness and safety in top uk patients
IntroductionThe TYSABRI® Observational Program (TOP) is an ongoing, global open-label study enrolling natalizumab-treated relapsing-remitting multiple sclerosis patients in real-wo...
The relationship between ethnicity and Multiple Sclerosis characteristics in the United Kingdom: a UK MS Register study
The relationship between ethnicity and Multiple Sclerosis characteristics in the United Kingdom: a UK MS Register study
Abstract
Previous studies have suggested differences in Multiple Sclerosis severity between individuals from different ethnic backgrounds. Howeve...
Is a Fitbit a Diary? Self-Tracking and Autobiography
Is a Fitbit a Diary? Self-Tracking and Autobiography
Data becomes something of a mirror in which people see themselves reflected. (Sorapure 270)In a 2014 essay for The New Yorker, the humourist David Sedaris recounts an obsession spu...